B & T Capital Management Dba Alpha Capital Management Invitae Corp Transaction History

B & T Capital Management Dba Alpha Capital Management

  • $495 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 23, 2021
SELL
$26.09 - $40.4 $167,184 - $258,883
-6,408 Closed
0 $0
Q1 2021

May 03, 2021
BUY
$33.06 - $56.93 $211,848 - $364,807
6,408 New
6,408 $245,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track B & T Capital Management Dba Alpha Capital Management Portfolio

Follow B & T Capital Management Dba Alpha Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B & T Capital Management Dba Alpha Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on B & T Capital Management Dba Alpha Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email